Rocket Pharmaceuticals
RCKT
RCKT
150 hedge funds and large institutions have $2.74B invested in Rocket Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 66 increasing their positions, 50 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
13% less funds holding
Funds holding: 173 → 150 (-23)
17% less funds holding in top 10
Funds holding in top 10: 6 → 5 (-1)
69% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 32
Holders
150
Holding in Top 10
5
Calls
$8.36M
Puts
$5.25M
Top Buyers
| 1 | +$44.3M | |
| 2 | +$24.8M | |
| 3 | +$18.3M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.1M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$8.37M |
Top Sellers
| 1 | -$32.1M | |
| 2 | -$17.7M | |
| 3 | -$16.4M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$10.9M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$8.86M |